These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19600)

  • 41. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.
    Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL
    J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of tetrahydrocannabinols II.
    Garrett ER; Gouyette AJ; Roseboom H
    J Pharm Sci; 1978 Jan; 67(1):27-32. PubMed ID: 22740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutral in vivo metabolites of cannabinol isolated from rat faeces.
    Yisak WA; Widman M; Lindgren JE; Agurell S
    J Pharm Pharmacol; 1977 Aug; 29(8):487-90. PubMed ID: 19598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The metabolism of drugs and other foreign compounds in suspensions of isolated rat hepatocytes.
    McMahon RE
    Ann N Y Acad Sci; 1980; 349():46-56. PubMed ID: 6261639
    [No Abstract]   [Full Text] [Related]  

  • 45. Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol.
    Watanabe K; Tanaka T; Yamamoto I; Yoshimura H
    Biochem Biophys Res Commun; 1988 Nov; 157(1):75-80. PubMed ID: 2848522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological activities in the mouse of delta 9-tetrahydrocannabinol metabolites oxidized at the 8-position.
    Narimatsu S; Matsubara K; Shimonishi T; Watanabe K; Yamamoto I; Yoshimura H
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):392-5. PubMed ID: 2988803
    [No Abstract]   [Full Text] [Related]  

  • 47. Interactions of cannabinoids with bovine serum albumin.
    Haque SJ; Poddar MK
    Biosci Rep; 1984 Mar; 4(3):239-43. PubMed ID: 6326885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromatographic analysis for delta1-tetrahydrocannabinol in blood and brain.
    McCallum NK; Shaw SM
    J Anal Toxicol; 1981; 5(3):148-9. PubMed ID: 6267374
    [No Abstract]   [Full Text] [Related]  

  • 49. The synthesis of two metabolites of (-)- 8 -tetrahydrocannabinol.
    Fahrenholtz KE
    J Org Chem; 1972 Jun; 37(13):2204-7. PubMed ID: 5037058
    [No Abstract]   [Full Text] [Related]  

  • 50. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
    McCallum ND; Yagen B; Levy S; Mechoulam R
    Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of the in vivo liver metabolites of (--)-delta 7-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Gill EW; Slater M; Paton WD
    Drug Metab Dispos; 1980; 8(6):439-45. PubMed ID: 6109613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A one-step synthesis of (-)-delta1- tetrahydrocannabinol from chrysanthenol.
    Razdan RK; Handrick GR; Dalzell HC
    Experientia; 1975 Jan; 31(1):16-7. PubMed ID: 1112309
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibody-mediated extraction of the main tetrahydrocannabinol metabolite, 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid, from human urine and its identification by gas chromatography-mass spectrometry in the sub-nanogram range.
    Lemm U; Tenczer J; Baudisch H; Krause W
    J Chromatogr; 1985 Aug; 342(2):393-8. PubMed ID: 2997252
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Paton WD
    Drug Metab Dispos; 1980; 8(3):178-86. PubMed ID: 6104583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
    Gill EW; Lawrence DK
    J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
    [No Abstract]   [Full Text] [Related]  

  • 56. Combined high-pressure liquid chromatography and radioimmunoassay method for the quantitation of delta 9-tetrahydrocannabinol and some of its metabolites in human plasma.
    Williams PL; Moffat AC; King LJ
    J Chromatogr; 1978 Aug; 155(2):273-83. PubMed ID: 681490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites.
    Jones G; Widman M; Agurell S; Lindgren JE
    Acta Pharm Suec; 1974 Jun; 11(3):283-94. PubMed ID: 4839738
    [No Abstract]   [Full Text] [Related]  

  • 58. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol.
    Garrett ER; Hunt CA
    J Pharm Sci; 1974 Jul; 63(7):1056-64. PubMed ID: 4853640
    [No Abstract]   [Full Text] [Related]  

  • 59. Identification of cannabivarins in hashish by a new method of combined gas chromatography-mass-spectrometry.
    Vree TB; Breimer DD; van Ginneken CA; van Rossum JM; de Zeeuw RA; Witte AH
    Clin Chim Acta; 1971 Sep; 34(2):365-72. PubMed ID: 5113572
    [No Abstract]   [Full Text] [Related]  

  • 60. Oxidative cleavage of the pentyl side-chain of cannabinoids. Identification of new biotransformation pathways in the metabolism of 4'-hydroxy-delta-9-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Drug Metab Dispos; 1990; 18(3):350-5. PubMed ID: 1974198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.